Research progress of changes in thyroid function in short stature children both before and after therapy

矮身材是指在相似生活环境下,同种族、性别和年龄的个体身高低于健康人群平均身高2个标准差者,或低于第3百分位数者,其病因主要包括生长激素缺乏症、甲状腺功能减低症、特发性矮小、Turner综合征等.应用基因重组人生长激素(rhGH)治疗矮身材患儿前后,及时发现患儿甲状腺功能变化,甲状腺功能减低者适时补充甲状腺素,维持甲状腺功能正常,有助于rhGH更好地达到预期治疗效果.Short stature refers to the individual of the same race,gender and age,whose height is lower than the average height for about 2 standard deviations or under the 3rd percentile in the similar living environment.Its etiology mainly includes growth hormone deficiency,hypothyroidism,idiopathic short stature,Turner syndrome and so on.Short stature can be treated in childhood with recombinant human growth hormone (rhGH).Clinical evidence suggests that doctors should pay attention to thyroid hormone levels before and after rhGH therapy,so that they can offer thyroxine timely and maintain normal thyroid function for the children with hypothyroidism,which can improve the efficacy of rhGH in children with short stature.中国科技核心期刊(ISTIC)中国科学引文数据库(CSCD)201595-15973